Company / EPS (Diluted)
Disc Medicine, Inc. EPS (Diluted) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$6.01
FY2025
5-year range
-$45.05 / -$3.42
FY2021-FY2025
Trend
-51.8%
vs FY2024
Sector context
#187 of 204
Health Care
What the data says
Among 204 Health Care companies, Disc Medicine, Inc. is in the bottom 8% for eps (diluted). Declined from $-3.42 to $-6.01 over the past 2 years.
Based on SEC 10-K filings.
-6.01 in FY2025.
Declined from $-3.42 to $-6.01 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 204This company -$6.01 Sector average -$0.98
▼
-513.5% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 51.8% year-over-year.
- Ranks #187 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.01 | -51.8% |
| FY2024 | -$3.96 | -15.8% |
| FY2023 | -$3.42 | +92.4% |
| FY2022 | -$45.05 | -10.0% |
| FY2021 | -$40.95 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026